RAF-1 over-expression does condition survival of patients affected by aggressive mantle cell lymphoma.
Nagy
Bálint
B
Galimberti
Sara
S
Benedetti
Edoardo
E
Caracciolo
Francesco
F
Pacini
Simone
S
Vilpo
Juhani
J
Ferrer
Anna
A
Elonen
Erkki
E
Franssila
Kaarle
K
Knuutila
Sakari
S
Petrini
Mario
M
D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001483:Base Sequence; D017931:DNA Primers; D005260:Female; D006801:Humans; D020522:Lymphoma, Mantle-Cell / Q000188:drug therapy / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D019908:Proto-Oncogene Proteins c-raf / Q000235:genetics*; D000069283:Rituximab; D016019:Survival Analysis
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D017931:DNA Primers; D000069283:Rituximab; D019908:Proto-Oncogene Proteins c-raf